Ascorbate elevates perfusion pressure in the bovine extraocular long posterior ciliary artery: Role of endothelium-derived hyperpolarizing factor (EDHF)

European Journal of Pharmacology

Volumn 534, Issue 1-3, 2006, Pages 152-158

  Stirrat, Alison ^a   Nelli, Silvia ^a   McGuckin, Alicia ^a   Ho, Vivian Wing Man ^a   Wilson, William S ^a   Martin, William ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Ascorbate; EDHF (endothelium derived hyperpolarizing factor); Flow; Flow dependent vasodilatation; Perfusion pressure; Vasodilatation

Indexed keywords

1 ((2 CHLOROPHENYL)DIPHENYLMETHYL) 1H PYRAZOLE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ASCORBIC ACID; CLOTRIMAZOLE; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; NITRIC OXIDE; PROSTANOID; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CILIARY ARTERY; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; ENDOTHELIUM CELL; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; ASCORBIC ACID; BIOLOGICAL FACTORS; CATTLE; CILIARY ARTERIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; PERFUSION; POTASSIUM CHANNEL BLOCKERS; PRESSURE; PYRAZOLES; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 33644884163     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.01.029     Document Type: Article

References (33)

1. A.S.O. Adeagbo Endothelium-derived hyperpolarizing factor. Characterization as a cytochrome P4501A-linked metabolite of arachidonic acid in perfused rat mesenteric prearteriolar bed Am. J. Hypertens. 10 1997 763 771
2. Ca channels Circulation 107 2003 769 776
3. Y.C. Boo, and H. Jo Flow-dependent regulation of endothelial nitric oxide synthase: role of protein kinases Am. J. Physiol. 285 2003 C499 C508
4. R. Busse, and I. Fleming Regulation of endothelium-derived vasoactive autocoid production by hemodynamic forces Trends Pharmacol. Sci. 24 2003 24 29
5. R. Busse, G. Edwards, M. Félétou, I. Fleming, P.M. Vanhoutte, and A.H. Weston EDHF: bringing the concepts together Trends Pharmacol. Sci. 23 2002 374 380
6. W.B. Campbell, and D.R. Harder Prologue: EDHF-what is it? Am. J. Physiol. 280 2001 H2413 H2416
7. + channels as targets for specific immunomodulation Trends Pharmacol. Sci. 25 2004 280 289
8. H.A. Coleman, M. Tare, and H.C. Parkington Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease Clin. Exp. Pharmacol. Physiol. 31 2004 641 649
9. R. Collins, J. Armitage, S. Parish, P. Sleight, and P. Peto MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 23 33
10. N.S. Cook, and U. Quast Potassium channel pharmacology Potassium channels: structure, classification, function and therapeutic potential 1990 Ellis Harwood Chichester 181 255
11. G.J. Crane, N. Gallagher, K.A. Dora, and C.J. Garland Small- and intermediate-conductance calcium-activated K+ channels provide different facets of endothelium-dependent hyperpolarization in rat mesenteric artery J. Physiol. 553 2003 183 189
12. 2-independent vasorelaxation and the cytochrome P450 pathway in rabbit carotid artery Br. J. Pharmacol. 120 1997 695 701
13. H. Dong, Y. Jiang, W.C. Cole, and C.R. Triggle Comparison of the pharmacological properties of EDHF-mediated vasorelaxation in guinea-pig cerebral and mesenteric resistance vessels Br. J. Pharmacol. 130 2000 1983 1991
14. J.M. Doughty, F. Plane, and P.D. Langton Charybdotoxin and apamin block EDHF in rat mesenteric artery if selectively applied to the endothelium Am. J. Physiol. 276 1999 H1107 H1112
15. G.R. Ellis, R.A. Anderson, Y.Y. Chirkov, J. Morris-Thurgood, S.K. Jackson, M.J. Lewis, J.D. Horowitz, and M.P. Frenneaux Acute effects of vitamin c on platelet responsiveness to nitric oxide donors and endothelial function in patients with chronic heart failure J. Cardiovasc. Pharmacol. 37 2001 564 570
16. T.M. Griffith Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis? Br. J. Pharmacol. 141 2004 881 903
17. A. Huang, D. Sun, A. Jacobson, M.A. Carroll, J.R. Falck, and G. Kaley Epoxyeicosatrienoic acids are released to mediate shear stress-dependent hyperpolarization of arteriolar smooth muscle Circ. Res. 96 2005 376 383
18. J.F. Keaney, and J.A. Vita Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor Prog. Cardiovasc. Dis. 38 1995 129 154
19. G.N. Levine, B. Frei, S.N. Koulouris, M.D. Gerhard, J.F. Keaney, and J.A. Vita Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease Circulation 93 1996 1107 1113
20. A.J. McNeish, W.S. Wilson, and W. Martin Dominant role of an endothelium-derived hyperpolarising factor (EDHF)-like vasodilator in the ciliary vascular bed of the bovine isolated perfused eye Br. J. Pharmacol. 134 2001 912 920
21. A.J. McNeish, W.S. Wilson, and W. Martin Ascorbate blocks endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation in the bovine ciliary vascular bed and rat mesentery Br. J. Pharmacol. 135 2002 1801 1809
22. A.J. McNeish, S. Nelli, W.S. Wilson, F.J. Dowell, and W. Martin Differential effects of ascorbate on endothelium-derived hyperpolarizing factor (EDHF)-mediated vasodilatation in the bovine ciliary vascular bed and coronary artery Br. J. Pharmacol. 138 2003 1172 1180
23. S. Moncada, R.M.J. Palmer, and E.A. Higgs Nitric oxide: physiology, pathophysiology and pharmacology Pharmacol. Rev. 43 1991 109 142
24. S. Nelli, F.J. Dowell, W.S. Wilson, A. Stirrat, and W. Martin Requirement for flow in the blockade of endothelium-derived hyperpolarizing factor (EDHF) by ascorbate in the bovine ciliary artery Br. J. Pharmacol. 142 2004 1081 1090
25. R. Popp, I. Fleming, and R. Busse Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor: a modulator of arterial compliance Circ. Res. 82 1998 696 703
26. M.D. Randall, and C.R. Hiley Detergent and methylene blue affect endothelium-dependent vasorelaxation and pressure/flow relations in rat blood perfused mesenteric arterial bed Br. J. Pharmacol. 95 1988 1081 1088
27. D. Sun, A. Huang, C.J. Smith, C.J. Stackpole, J.A. Connetta, E.G. Shesely, A. Koller, and G. Kaley Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice Circ. Res. 85 1999 288 293
28. S. Taddei, A. Virdis, L. Ghiadoni, A. Magagna, and A. Salvetti Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension Circulation 97 1998 2222 2229
29. H.H. Ting, F.K. Timmi, E.A. Haley, M.A. Roddy, P. Ganz, and M.A. Creager Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolaemia Circulation 95 1997 2617 2622
30. G.J. Waldron, and C.J. Garland Effect of potassium channel blockers on l-NAME insensitive relaxations in rat small mesenteric artery Can. J. Physiol. Pharm. 72 1994 11
31. X. Wang, G. Trottier, and R. Loutzenhiser Determinants of renal afferent arteriolar actions of bradykinin: evidence that multiple pathways mediate responses attributed to EDHF Am. J. Physiol. 285 2003 F540 F549
32. Ca1: a potential immunosuppressant Proc. Natl. Acad. Sci. U. S. A. 97 2000 8151 8156
33. P.M. Zygmunt, and E.D. Högestätt Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery Br. J. Pharmacol. 117 1996 1600 1606